WPRIM Management System> DCMS> National Journal of Andrology> 2005> 11> 4

Volume: 11 Issue: 4

1. Time effect window of sildenafil for the treatment of erectile dysfunction. Page:317—319
2. Advances in the treatment of erectile dysfunction by viagra. Page:314—319
3. Effect of eucommia ulmoides oliv on SOD activity and alpha-actin expression in the penile tissues of diabetic rats. Page:309—313
4. Advances in researches on inhibin B and male reproduction. Page:299—302
5. Advances in the treatment of Chlamydia trachomatis infection. Page:296—298
6. Morphological and molecular biological peculiarities of the experimental autoimmune prostatitis rat model. Page:290—295
7. Analysis of the causes of postoperative chest or/and abdomen colic in benign prostatic hyperplasia. Page:288—295
8. Prevention and treatment of the complications of inflatable penile prosthesis implantation. Page:284—287
9. Intracavernous pressure responses induced by electrical stimulation of penile dorsal nerves and intracavernosal drug injection in rats. Page:281—287
10. Expression of the kallikreins-kinins system in the corpus cavernosum of rats. Page:278—280
11. Etiology and treatment of bladder spasm associated with benign prostatic hyperplasia. Page:275—277
12. Feasibility of muscle-derived cell autotransplantation as a treatment for post-prostatectomy urinary incontinence. Page:272—277
13. Influence of electromagnetic irradiation on P450scc mRNA expression in rat testis tissues and protective effect of the shield. Page:269—271
14. Distribution of attractin protein and mRNA in the testis of rat of different ages. Page:264—268
15. Effects of pentachlorophenol on rat sertoli cells. Page:261—268
16. Impact of PC-1 gene knockdown on the biological action of prostate cancer cell line C4-2. Page:256—260
17. CTL epitopes modified by KDEL and recognized by CD8+ T lymphocytes to herpes simplex virus type 2 improve CTL effect. Page:252—255
18. Effects of mono(2-ethylhexyl) phthalate on testosterone biosynthesis in leydig cells cultured from the rat testis. Page:247—251
19. Chemoprevention of prostate cancer. Page:243—246